Theta-burst stimulation (TBS)
Theta-burst stimulation (TBS) is a medical device with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Theta-burst stimulation (TBS)Registry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia
Neurocircuit Strategy to Decrease Cocaine Cue Reactivity
Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS
The Utility of Concurrent TBS/fNIRS for Antidepressant Treatment Optimization
Probing Homeostatic Plasticity With Priming Theta-burst Stimulation of the Dorsolateral Prefrontal Cortex
Clinical Trials (5)
Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease Dementia
Neurocircuit Strategy to Decrease Cocaine Cue Reactivity
Predicting Illness Trajectories In Fully Remitted Major Depression Using Concurrent TBS/fNIRS
The Utility of Concurrent TBS/fNIRS for Antidepressant Treatment Optimization
Probing Homeostatic Plasticity With Priming Theta-burst Stimulation of the Dorsolateral Prefrontal Cortex
All 5 trials loaded
Drug Details
- Intervention Type
- Device
- Total Trials
- 5